组蛋白H3K18乳酸化预测脓毒症相关急性呼吸窘迫综合征的早期识别与预后:一项前瞻性观察性临床研究
该前瞻性观察性研究纳入2023年3月至2024年9月入住ICU的91例脓毒症患者(36例合并ARDS,55例未合并ARDS),于入ICU第1天采集支气管肺泡灌洗液检测H3K18la水平。结果显示,脓毒症相关ARDS组BALF中H3K18la水平显著高于非ARDS组和对照组(P<0.05),且H3K18la与乳酸、IL-6、TNF-α、APACHE II评分及SOFA评分呈正相关(P<0.01)。Logistic回归显示H3K18la是ARDS发生的独立预测因子(P<0.05),ROC曲线AUC=0.804;联合SOFA评分后AUC提升至0.830(敏感性88.9%,特异性67.3%)。死亡组患者第3天H3K18la水平显著升高。作者认为H3K18la是脓毒症相关ARDS早期识别和预后预测的有前景的生物标志物。
要点
- 脓毒症相关ARDS组BALF中H3K18la水平显著高于非ARDS组和对照组(P<0.05)。
- H3K18la是脓毒症患者发生ARDS的独立预测因子(P<0.05),单独预测AUC=0.804。
- H3K18la联合SOFA评分预测ARDS的AUC=0.830,敏感性88.9%,特异性67.3%。
- H3K18la与乳酸、IL-6、TNF-α、APACHE II评分及SOFA评分呈正相关(P<0.01)。
- 死亡组患者第3天BALF中H3K18la水平较第1天显著升高。
适用人群与场景
- 2023年3月至2024年9月入住ICU的脓毒症患者,共91例,其中合并ARDS 36例,未合并ARDS 55例。
- 所有参与者于入ICU第1天采集支气管肺泡灌洗液,需持续机械通气者于第3天再次采集。
研究设计与关键结果
- 研究类型:前瞻性观察性临床研究;样本量:91例脓毒症患者(ARDS组36例,非ARDS组55例)。
- 主要结果:BALF中H3K18la水平在脓毒症相关ARDS组显著高于非ARDS组和对照组(P<0.05);H3K18la与乳酸、IL-6、TNF-α、APACHE II评分及SOFA评分呈正相关(P<0.01)。
- Logistic回归显示H3K18la是ARDS发生的独立预测因子(P<0.05);ROC曲线AUC=0.804。
- H3K18la联合SOFA评分预测ARDS的AUC=0.830,敏感性88.9%,特异性67.3%。
- 死亡组患者第3天BALF中H3K18la水平较第1天显著升高。
证据类型、等级与局限
- 证据类型:前瞻性观察性临床研究;原文未报告证据等级或推荐强度。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为H3K18la是脓毒症相关ARDS早期识别和预后预测的有前景的生物标志物。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: This study aimed to investigate the predictive value of histone H3 lysine 18 lactylation (H3K18la) for the early identification and prognosis of sepsis-related acute respiratory distress syndrome (ARDS). Methods: This prospective observational study included patients with sepsis admitted to the intensive care unit (ICU) between March 2023 and September 2024. The patients were divided into two groups: the sepsis with ARDS group and the sepsis without ARDS group. Clinical data were collected within 24 h of ICU admission. Bronchoalveolar lavage fluid (BALF) samples were obtained on day 1 for all participants, and a second BALF sample was collected on day 3 from patients requiring continued mechanical ventilation. Results: In total, 91 sepsis patients were enrolled in the study: 36 with ARDS and 55 without ARDS. H3K18la levels in BALF were significantly higher in the sepsis-related ARDS group than in the non-ARDS group and the control group ( P < 0.05). Elevated H3K18la levels were positively correlated with inflammatory markers (lactate, IL-6, and TNF-α), Acute Physiology and Chronic Health Evaluation II scores, and Sequential Organ Failure Assessment scores ( P < 0.01). Logistic regression analysis revealed that H3K18la was an independent predictor of ARDS development ( P < 0.05), and ROC curve analysis revealed that H3K18la had high diagnostic accuracy (AUC = 0.804). Combining H3K18la with the Sequential Organ Failure Assessment score further improved diagnostic performance (AUC = 0.830, sensitivity = 88.9%, specificity = 67.3%). Furthermore, H3K18la levels significantly increased on day 3 in the mortality group. Conclusion: H3K18la is a promising biomarker for the early identification and prognostic prediction of sepsis-related ARDS.
参考来源
- Li X, Shang Y, Zhang J, et al. PREDICTIVE VALUE OF H3K18 LACTYLATION FOR EARLY DETECTION AND PROGNOSIS OF SEPSIS-RELATED ACUTE RESPIRATORY DISTRESS SYNDROME: A PROSPECTIVE OBSERVATIONAL CLINICAL STUDY. Shock. 2025. PMID: 40267500. doi:10.1097/SHK.0000000000002601
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。